Peter Keller, M.Sci.
Mr. Keller joined Selecta Biosciences from Abbott Laboratories in 2011. After the acquisition of Solvay Pharmaceuticals in 2010 by Abbott Laboratories, he led the integration process for five R&D and manufacturing facilities in Europe. Before the acquisition, Mr. Keller was Vice President, Head of Mergers & Acquisitions and Alliance Management at Solvay Pharmaceuticals, from 2007 to 2010, where he negotiated license and acquisition agreements in various therapeutic areas such as vaccines, neurology and cardiology.
He was the lead negotiator for the $1.5 billion fenofibrate alliance between Solvay Pharmaceuticals and Abbott Laboratories and instrumental in the $6.2 billion acquisition of Solvay Pharmaceuticals by Abbott Laboratories. Mr. Keller previously worked in management consulting at McKinsey & Company, from 2000 to 2007, and Simon Kucher & Partners, from 1998 to 2000. Mr. Keller received his M.Sci. in Industrial Engineering and Management from the Technical University of Karlsruhe in Karlsruhe, Germany.